Keith Kellum, MD
Ophthalmology · Houma, LANPI 1225036023
Payments from drug & device makers
Across 362 payments — averaging $62.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rxsight Inc$13K
- AbbVie$2K
- Alcon$2K
- Ivantis, Inc$808
- Sight Sciences, Inc.$738
- Lumenis BE Inc$663
- plus $4K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rxsight Inc | 11 | $12,568 |
| AbbVie(2 entities) | 128 | $2,307 |
| Alcon | 64 | $2,059 |
| Ivantis, Inc | 21 | $808 |
| Sight Sciences, Inc. | 10 | $738 |
| Lumenis BE Inc | 1 | $663 |
| Oyster Point Pharma, Inc. | 18 | $484 |
| Glaukos Corporation | 5 | $321 |
| Bausch & Lomb Americas Inc. | 13 | $284 |
| Sun Pharmaceutical Industries Inc. | 14 | $261 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $250 |
| NEW World Medical,inc. | 5 | $232 |
| Dompe US, Inc. | 6 | $184 |
| Amgen(2 entities) | 9 | $180 |
| Regeneron Healthcare Solutions, Inc. | 2 | $156 |
| Harrow Eye, LLC | 6 | $154 |
| Iridex Corporation | 1 | $150 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $122 |
| Apellis Pharmaceuticals, Inc. | 2 | $121 |
| Aerie Pharmaceuticals, Inc. | 6 | $94 |
| Carl Zeiss Meditec USA, Inc. | 1 | $94 |
| Biotissue Holdings Inc. | 5 | $83 |
| Kala Pharmaceuticals, Inc. | 4 | $76 |
| Genentech USA, Inc. | 3 | $54 |
| Novartis | 3 | $47 |
| Tarsus Pharmaceuticals, Inc. | 3 | $46 |
| Mallinckrodt Hospital Products Inc. | 2 | $44 |
| Rayner Intraocular Lenses Limited | 1 | $32 |
| Ocular Therapeutix, Inc. | 2 | $30 |
| Coherus Oncology, Inc. | 1 | $25 |
| Johnson & Johnson Vision Care, Inc. | 1 | $13 |
How this compares
$22,680 in reported general payments places this provider in the 90th percentile of 286 ophthalmology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Houma
- Arthur DelahoussayeHouma$26K
- Aravinda RaoHouma$8K
- Blake WilliamsonBaton Rouge$482K
- William ReadMonroe$303K
- Delmar CaldwellNew Orleans$282K
- Ruben GrigorianWest Monroe$192K
- Eric ReishAlexandria$158K
- Wyche ColemanShreveport$130K
- Ze ZhangNew Orleans$103K
- Rebecca MetzingerNew Orleans$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.